Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mary D. Ruppe
Pharmacokinetics and Pharmacodynamics of a Human Monoclonal Anti-Fgf23 Antibody (KRN23) in the First Multiple Ascending-Dose Trial Treating Adults With X-Linked Hypophosphatemia
Journal of Clinical Pharmacology
Pharmacology
The Parathyroid Gland and Heart Disease
Methodist DeBakey cardiovascular journal
Medicine
Related publications
Pharmacokinetics and Pharmacodynamics of Two Multiple-Dose Piperacillin-Tazobactam Regimens.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Pharmacokinetics and Pharmacodynamics of Multiple-Dose Intravenous Nemonoxacin in Healthy Chinese Volunteers
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
X-Linked Hypophosphatemia: New Horizons
Clinical Pediatric Endocrinology
Child Health
Endocrinology
Perinatology
Pediatrics
Metabolism
Diabetes
Single Ascending Dose Safety and Pharmacokinetics of CDRI-97/78: First-In-Human Study of a Novel Antimalarial Drug
Malaria Research and Treatment
Epidemiology
Infectious Diseases
A Randomized, Placebo-Controlled, Multiple-Ascending-Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Soluble Guanylate Cyclase Stimulator Praliciguat in Healthy Subjects
Clinical Pharmacology in Drug Development
Pharmacology
Pharmaceutical Science
SAT0235 BIIB059, a Monoclonal Antibody Targeting BCDA2 Shows Safety, Tolerability, Pharmacokinetics, Pharmacodynamics in Healthy Volunteer Subjects
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Anti-Cd38 Cytolytic Antibody TAK-079 in Healthy Subjects
British Journal of Clinical Pharmacology
Pharmacology
First-In-Human, Phase I Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of RO5126766, a First-In-Class Dual MEK/RAF Inhibitor in Patients With Solid Tumors
Clinical Cancer Research
Cancer Research
Oncology
Human Anti–Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease: The CLASSIC-I Trial
Gastroenterology
Hepatology
Gastroenterology
